NCT05942833

Brief Summary

Patients presenting in hospital with symptoms of acute diverticulitis. Acute inflammation of the left-sided colon is confirmed with CT scan or ultrasound in experienced centers and diagnosis is defined according to the "Classification of Diverticular Disease (CDD)". CDD Type 2a, 2b and 3b will be included and then randomized in two groups. Group A will get an early left hemicolectomy 7 to 10 days after admission and initial antibiotic therapy and/or drainage of the abscess. Group B is designated for an elective resection 6 to 8 weeks after dismissal at the earliest and initial conservative treatment and/or after drainage of the abscess. Six weeks after the operation patients of Group A will be asked for their present quality of life with a standardized scoring system (Gastrointestinal Quality of Life Index = GIQLI; Short-form 36 Score = SF-36 Score; Low anterior resection syndrome = LARS Score). Group B (elective resection) will be asked at their readmission prior to elective surgery is done. This survey package will be repeated again 6 to 8 weeks later in both groups. Primary endpoints will be the two GIQLI at the said examination times. Secondary endpoints will be SF-36 score, LARS-score, GIQLI-Domains, anastomosis insufficiency and other complications, mortality and length of hospital stay. Comparisons between the groups are made at the said examination times but also 6-8 weeks after the operation.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jan 2023Jul 2027

Study Start

First participant enrolled

January 16, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3.9 years

First QC Date

June 7, 2023

Last Update Submit

March 16, 2026

Conditions

Keywords

Recurrent diverticulitisQuality of lifeAcute complicated DiverticulitisEarly resectionElective resection

Outcome Measures

Primary Outcomes (1)

  • Gastrointestinal Quality of Life Index

    Quality of Life

    Up to 18 weeks

Secondary Outcomes (8)

  • SF-36 score (Short form score)

    Up to 18 weeks

  • Low anterior resection syndrome score

    Up to 18 weeks

  • Anastomosis insufficiency

    Up to 18 weeks

  • Intraoperative complication

    Up to 18 weeks

  • Exitus

    Up to 18 weeks

  • +3 more secondary outcomes

Study Arms (2)

Group A (Early)

EXPERIMENTAL

Early left hemicolectomy immediately up to a maximum of 2 days after 7-10 days lasting initial conservative or interventional treatment (e.g: antibiotics, analgesics, drainage) and CT scan/ultrasound proven left-sided colonic diverticulitis

Procedure: Sigmoid resection

Group B (Late)

OTHER

Elective left hemicolectomy 6 to 8 weeks after 7-10 days lasting initial conservative or interventional treatment (e.g: antibiotics, analgesics, drainage) and CT scan/ultrasound proven left-sided colonic diverticulitis

Procedure: Sigmoid resection

Interventions

Timing of sigmoid resection

Group A (Early)Group B (Late)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent to participate in the study
  • CDD Type 2a, 2b: acute complicated left-sided diverticulitis
  • CDD Type 3b: relapsing diverticulitis without complications (\>2 episodes within 2 years)
  • Acute presentation
  • Inflammation located in the left-sided colon
  • Inflammation is CT proven or ultrasound confirmed from experienced radiologists

You may not qualify if:

  • \< 18 years
  • Pregnancy
  • BMI \> 55kg/m2
  • Current colorectal carcinoma in the left-sided colon
  • Oral and/or intravenous corticosteroid
  • Ongoing chemotherapy
  • Status post left hemicolectomy
  • Patients who cannot take care of themselves at home or are unable to follow instructions
  • Patients who are not fit for surgery (anesthesia, expert knowledge from specialists) and will not benefit from surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Ordensklinikum Elisabethinen Linz

Linz, Austria, 4020, Austria

RECRUITING

Krankenhaus Barmherzige Schwestern Linz

Linz, Upper Austria, 4010, Austria

RECRUITING

Kepler University Hospital

Linz, Upper Austria, 4020, Austria

RECRUITING

Universitätsklinikum Mannheim

Mannheim, Mannheim, 68167, Germany

NOT YET RECRUITING

MeSH Terms

Conditions

Diverticulitis

Condition Hierarchy (Ancestors)

Diverticular DiseasesGastroenteritisGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Andreas Shamiyeh, Dr.

    Kepler University Hospital Linz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective, randomized controlled
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2023

First Posted

July 12, 2023

Study Start

January 16, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations